| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | glucuronosyltransferase activity | 3.08e-10 | 35 | 162 | 8 | GO:0015020 | |
| GeneOntologyMolecularFunction | retinoic acid binding | 2.08e-09 | 28 | 162 | 7 | GO:0001972 | |
| GeneOntologyMolecularFunction | retinoid binding | 4.52e-09 | 48 | 162 | 8 | GO:0005501 | |
| GeneOntologyMolecularFunction | isoprenoid binding | 5.36e-09 | 49 | 162 | 8 | GO:0019840 | |
| GeneOntologyMolecularFunction | UDP-glycosyltransferase activity | UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 GCNT1 UGT1A4 UGT1A3 XYLT2 CHPF2 | 4.96e-07 | 153 | 162 | 10 | GO:0008194 |
| GeneOntologyMolecularFunction | hexosyltransferase activity | UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 GCNT1 UGT1A4 UGT1A3 CHPF2 FUT5 FUT6 | 1.25e-06 | 211 | 162 | 11 | GO:0016758 |
| GeneOntologyMolecularFunction | glycosyltransferase activity | UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 GCNT1 UGT1A4 UGT1A3 XYLT2 CHPF2 FUT5 FUT6 | 4.24e-06 | 288 | 162 | 12 | GO:0016757 |
| GeneOntologyMolecularFunction | monocarboxylic acid binding | 2.68e-05 | 107 | 162 | 7 | GO:0033293 | |
| GeneOntologyMolecularFunction | exopeptidase activity | 3.21e-05 | 110 | 162 | 7 | GO:0008238 | |
| GeneOntologyMolecularFunction | 4-hydroxybutyrate receptor activity | 6.54e-05 | 2 | 162 | 2 | GO:0062124 | |
| GeneOntologyMolecularFunction | D-ribulose-phosphate 3-epimerase activity | 6.54e-05 | 2 | 162 | 2 | GO:0004750 | |
| GeneOntologyMolecularFunction | peptidase activity | DPP4 RELN SCRN3 UFSP2 ANPEP HTRA2 KLK14 ERMP1 F2 FAM111B DPEP3 CPNE1 ERVK-19 CTRB1 MMP17 METAP2 | 8.69e-05 | 654 | 162 | 16 | GO:0008233 |
| GeneOntologyMolecularFunction | protein homodimerization activity | PCYT1A DPP4 LILRA1 AOC1 UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 TXNRD2 UGT1A4 UGT1A3 RPEL1 NECTIN2 TMEM132A TENM1 CDADC1 RPE | 1.14e-04 | 815 | 162 | 18 | GO:0042803 |
| GeneOntologyMolecularFunction | carboxylic acid binding | SIGLEC8 UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 UGT1A4 UGT1A3 DMBT1 | 1.50e-04 | 239 | 162 | 9 | GO:0031406 |
| GeneOntologyMolecularFunction | organic acid binding | SIGLEC8 UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 UGT1A4 UGT1A3 DMBT1 | 2.36e-04 | 254 | 162 | 9 | GO:0043177 |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | GABRB2 IL11RA OR2A14 IL13RA1 LILRA1 ITGA11 NPR1 LILRA3 DRD4 MYOT GPR27 SIGLEC8 GRIN2C GRM1 CHRNA5 CD3E NRXN3 PTPRH PTPRM OPN5 FCRL5 IL3RA FCAMR GPR151 | 2.41e-04 | 1353 | 162 | 24 | GO:0004888 |
| GeneOntologyMolecularFunction | metalloexopeptidase activity | 2.61e-04 | 70 | 162 | 5 | GO:0008235 | |
| GeneOntologyMolecularFunction | postsynaptic neurotransmitter receptor activity | 3.61e-04 | 75 | 162 | 5 | GO:0098960 | |
| GeneOntologyMolecularFunction | ISG15 transferase activity | 3.88e-04 | 4 | 162 | 2 | GO:0042296 | |
| GeneOntologyMolecularFunction | aminopeptidase activity | 4.03e-04 | 43 | 162 | 4 | GO:0004177 | |
| GeneOntologyMolecularFunction | virus receptor activity | 6.43e-04 | 85 | 162 | 5 | GO:0001618 | |
| GeneOntologyMolecularFunction | endopolyphosphatase activity | 6.44e-04 | 5 | 162 | 2 | GO:0000298 | |
| GeneOntologyMolecularFunction | tRNA (uridine) methyltransferase activity | 6.44e-04 | 5 | 162 | 2 | GO:0016300 | |
| GeneOntologyMolecularFunction | bis(5'-adenosyl)-hexaphosphatase activity | 6.44e-04 | 5 | 162 | 2 | GO:0034431 | |
| GeneOntologyMolecularFunction | diphosphoinositol-polyphosphate diphosphatase activity | 6.44e-04 | 5 | 162 | 2 | GO:0008486 | |
| GeneOntologyMolecularFunction | exogenous protein binding | 6.78e-04 | 86 | 162 | 5 | GO:0140272 | |
| GeneOntologyMolecularFunction | riboflavin transmembrane transporter activity | 9.60e-04 | 6 | 162 | 2 | GO:0032217 | |
| GeneOntologyMolecularFunction | 4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase activity | 9.60e-04 | 6 | 162 | 2 | GO:0017083 | |
| GeneOntologyMolecularFunction | bis(5'-adenosyl)-pentaphosphatase activity | 9.60e-04 | 6 | 162 | 2 | GO:0034432 | |
| GeneOntologyMolecularFunction | metalloaminopeptidase activity | 1.19e-03 | 26 | 162 | 3 | GO:0070006 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity | 1.34e-03 | 100 | 162 | 5 | GO:0030594 | |
| GeneOntologyMolecularFunction | alpha-(1->3)-fucosyltransferase activity | 1.77e-03 | 8 | 162 | 2 | GO:0046920 | |
| GeneOntologyMolecularFunction | protein kinase C binding | 2.04e-03 | 66 | 162 | 4 | GO:0005080 | |
| GeneOntologyMolecularFunction | primary methylamine oxidase activity | 2.27e-03 | 9 | 162 | 2 | GO:0008131 | |
| GeneOntologyMolecularFunction | fatty acid binding | 2.40e-03 | 69 | 162 | 4 | GO:0005504 | |
| GeneOntologyMolecularFunction | lipid binding | PITPNM2 PCYT1A UGT1A10 UGT1A8 UGT1A7 UGT1A5 AKR1D1 UGT1A9 TTPAL SNX16 F2 ITPR2 UGT1A4 UGT1A3 CPNE1 OPN5 DMBT1 | 2.82e-03 | 988 | 162 | 17 | GO:0008289 |
| GeneOntologyBiologicalProcess | cellular glucuronidation | 1.57e-10 | 21 | 160 | 7 | GO:0052695 | |
| GeneOntologyBiologicalProcess | glucuronate metabolic process | 8.61e-10 | 26 | 160 | 7 | GO:0019585 | |
| GeneOntologyBiologicalProcess | uronic acid metabolic process | 8.61e-10 | 26 | 160 | 7 | GO:0006063 | |
| GeneOntologyBiologicalProcess | hormone catabolic process | 9.77e-09 | 21 | 160 | 6 | GO:0042447 | |
| GeneOntologyBiologicalProcess | estrogen catabolic process | 1.73e-08 | 5 | 160 | 4 | GO:0006711 | |
| GeneOntologyBiologicalProcess | flavonoid glucuronidation | 1.73e-08 | 5 | 160 | 4 | GO:0052696 | |
| GeneOntologyBiologicalProcess | flavonoid metabolic process | 3.23e-08 | 13 | 160 | 5 | GO:0009812 | |
| GeneOntologyBiologicalProcess | phenylpropanoid catabolic process | 5.17e-08 | 6 | 160 | 4 | GO:0046271 | |
| GeneOntologyBiologicalProcess | coumarin catabolic process | 5.17e-08 | 6 | 160 | 4 | GO:0046226 | |
| GeneOntologyBiologicalProcess | flavone metabolic process | 5.17e-08 | 6 | 160 | 4 | GO:0051552 | |
| GeneOntologyBiologicalProcess | steroid catabolic process | 2.23e-07 | 34 | 160 | 6 | GO:0006706 | |
| GeneOntologyBiologicalProcess | phenylpropanoid metabolic process | 7.06e-07 | 10 | 160 | 4 | GO:0009698 | |
| GeneOntologyBiologicalProcess | coumarin metabolic process | 7.06e-07 | 10 | 160 | 4 | GO:0009804 | |
| GeneOntologyBiologicalProcess | xenobiotic glucuronidation | 1.64e-06 | 12 | 160 | 4 | GO:0052697 | |
| GeneOntologyBiologicalProcess | estrogen metabolic process | 3.01e-06 | 52 | 160 | 6 | GO:0008210 | |
| GeneOntologyBiologicalProcess | hormone metabolic process | DPP4 RELN UGT1A10 UGT1A8 UGT1A7 CYP19A1 AKR1D1 UGT1A9 UGT1A3 KCNMA1 DIO3 | 1.50e-05 | 286 | 160 | 11 | GO:0042445 |
| GeneOntologyBiologicalProcess | retinoic acid metabolic process | 2.56e-04 | 40 | 160 | 4 | GO:0042573 | |
| GeneOntologyBiologicalProcess | regulation of hormone levels | DPP4 RELN GPR27 UGT1A10 UGT1A8 UGT1A7 CYP19A1 AKR1D1 SLC17A4 UGT1A9 F2 EDN3 UGT1A3 KCNMA1 DIO3 | 2.91e-04 | 684 | 160 | 15 | GO:0010817 |
| GeneOntologyCellularComponent | side of membrane | IL11RA RGMB IL13RA1 LILRA1 ITGA11 ANPEP HTRA2 SIGLEC8 BCAN F2 CD3E NTNG2 UMODL1 DPEP3 PKHD1 KCNMA1 FCRL5 MMP17 IL3RA PDCD1LG2 | 2.15e-05 | 875 | 166 | 20 | GO:0098552 |
| GeneOntologyCellularComponent | external side of plasma membrane | IL11RA IL13RA1 LILRA1 ITGA11 ANPEP SIGLEC8 F2 CD3E UMODL1 PKHD1 KCNMA1 FCRL5 IL3RA PDCD1LG2 | 7.12e-05 | 519 | 166 | 14 | GO:0009897 |
| GeneOntologyCellularComponent | receptor complex | GABRB2 IL11RA IL13RA1 ITGA11 NPR1 HTRA2 GRIN2C GRM1 CHRNA5 ITPR2 CD3E IGHE FCRL5 IL3RA | 2.31e-04 | 581 | 166 | 14 | GO:0043235 |
| GeneOntologyCellularComponent | cell surface | IL11RA DPP4 IL13RA1 LILRA1 ITGA11 ANPEP SIGLEC8 BCAN DCSTAMP F2 CD3E UMODL1 NECTIN2 PKHD1 KCNMA1 FCRL5 IL3RA CDON IL27 PDCD1LG2 | 5.33e-04 | 1111 | 166 | 20 | GO:0009986 |
| Domain | Ig-like_fold | IL11RA IL13RA1 FLNC COL7A1 LILRA1 LILRA3 MYOT COL20A1 SIGLEC8 BCAN CD3E PTPRH PTPRM UMODL1 IGHE NCAN NECTIN2 PKHD1 ALPK3 RIMBP2 MYOM2 FCRL5 IL3RA SDK1 FCAMR CDON PDCD1LG2 | 6.05e-11 | 706 | 160 | 27 | IPR013783 |
| Domain | UDPGT | 3.12e-10 | 21 | 160 | 7 | PF00201 | |
| Domain | UDPGT | 3.12e-10 | 21 | 160 | 7 | PS00375 | |
| Domain | UDP_glucos_trans | 3.12e-10 | 21 | 160 | 7 | IPR002213 | |
| Domain | - | IL11RA IL13RA1 FLNC COL7A1 LILRA1 LILRA3 MYOT COL20A1 SIGLEC8 BCAN CD3E PTPRM UMODL1 NCAN NECTIN2 PKHD1 ALPK3 RIMBP2 MYOM2 FCRL5 IL3RA SDK1 FCAMR CDON PDCD1LG2 | 4.53e-10 | 663 | 160 | 25 | 2.60.40.10 |
| Domain | FN3_dom | IL11RA IL13RA1 FLNC COL7A1 COL20A1 PTPRH PTPRM UMODL1 RIMBP2 MYOM2 IL3RA SDK1 CDON | 3.07e-08 | 209 | 160 | 13 | IPR003961 |
| Domain | IG_LIKE | IL11RA LILRA1 LILRA3 MYOT SIGLEC8 BCAN CD3E PTPRM IGHE NCAN NECTIN2 ALPK3 MYOM2 FCRL5 SDK1 FCAMR CDON PDCD1LG2 | 2.31e-07 | 491 | 160 | 18 | PS50835 |
| Domain | Ig-like_dom | IL11RA LILRA1 LILRA3 MYOT SIGLEC8 BCAN CD3E PTPRM IGHE NCAN NECTIN2 ALPK3 MYOM2 FCRL5 SDK1 FCAMR CDON PDCD1LG2 | 3.29e-07 | 503 | 160 | 18 | IPR007110 |
| Domain | FN3 | IL11RA FLNC COL7A1 COL20A1 PTPRH PTPRM UMODL1 RIMBP2 MYOM2 SDK1 CDON | 5.77e-07 | 185 | 160 | 11 | SM00060 |
| Domain | IG | IL11RA LILRA1 LILRA3 MYOT SIGLEC8 BCAN PTPRM NCAN NECTIN2 ALPK3 MYOM2 FCRL5 SDK1 FCAMR CDON PDCD1LG2 | 7.01e-07 | 421 | 160 | 16 | SM00409 |
| Domain | Ig_sub | IL11RA LILRA1 LILRA3 MYOT SIGLEC8 BCAN PTPRM NCAN NECTIN2 ALPK3 MYOM2 FCRL5 SDK1 FCAMR CDON PDCD1LG2 | 7.01e-07 | 421 | 160 | 16 | IPR003599 |
| Domain | FN3 | IL11RA IL13RA1 COL7A1 COL20A1 PTPRH PTPRM UMODL1 RIMBP2 MYOM2 SDK1 CDON | 1.19e-06 | 199 | 160 | 11 | PS50853 |
| Domain | fn3 | IL11RA COL7A1 COL20A1 PTPRH PTPRM UMODL1 RIMBP2 MYOM2 SDK1 CDON | 1.36e-06 | 162 | 160 | 10 | PF00041 |
| Domain | IGc2 | 3.60e-05 | 235 | 160 | 10 | SM00408 | |
| Domain | Ig_sub2 | 3.60e-05 | 235 | 160 | 10 | IPR003598 | |
| Domain | ig | 3.89e-05 | 190 | 160 | 9 | PF00047 | |
| Domain | Immunoglobulin | 3.89e-05 | 190 | 160 | 9 | IPR013151 | |
| Domain | Ribul_P_3_epim | 7.29e-05 | 2 | 160 | 2 | PF00834 | |
| Domain | RIBUL_P_3_EPIMER_1 | 7.29e-05 | 2 | 160 | 2 | PS01085 | |
| Domain | Ribul_P_3_epim | 7.29e-05 | 2 | 160 | 2 | IPR026019 | |
| Domain | Ribul_P_3_epim-like | 7.29e-05 | 2 | 160 | 2 | IPR000056 | |
| Domain | Riboflavin_transptr | 2.18e-04 | 3 | 160 | 2 | IPR009357 | |
| Domain | RibuloseP-bd_barrel | 2.18e-04 | 3 | 160 | 2 | IPR011060 | |
| Domain | DUF1011 | 2.18e-04 | 3 | 160 | 2 | PF06237 | |
| Domain | Uroplakin-3 | 2.18e-04 | 3 | 160 | 2 | IPR024831 | |
| Domain | HEMATOPO_REC_S_F2 | 7.17e-04 | 5 | 160 | 2 | PS01356 | |
| Domain | Short_hematopoietin_rcpt_2_CS | 7.17e-04 | 5 | 160 | 2 | IPR003532 | |
| Domain | EGF | 9.66e-04 | 235 | 160 | 8 | SM00181 | |
| Domain | A1B_glyco/leuk_Ig-like_rcpt | 1.07e-03 | 6 | 160 | 2 | IPR016332 | |
| Domain | EGF-like_dom | 1.40e-03 | 249 | 160 | 8 | IPR000742 | |
| Pathway | KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS | 1.63e-12 | 28 | 126 | 9 | M19580 | |
| Pathway | REACTOME_GLUCURONIDATION | 1.18e-09 | 24 | 126 | 7 | MM14599 | |
| Pathway | KEGG_STEROID_HORMONE_BIOSYNTHESIS | UGT1A10 UGT1A8 UGT1A7 UGT1A5 CYP19A1 AKR1D1 UGT1A9 UGT1A4 UGT1A3 | 1.23e-09 | 55 | 126 | 9 | M14933 |
| Pathway | REACTOME_GLUCURONIDATION | 1.62e-09 | 25 | 126 | 7 | M17787 | |
| Pathway | WP_GLUCURONIDATION | 1.62e-09 | 25 | 126 | 7 | MM15820 | |
| Pathway | KEGG_ASCORBATE_AND_ALDARATE_METABOLISM | 1.62e-09 | 25 | 126 | 7 | M605 | |
| Pathway | WP_GLUCURONIDATION | 2.20e-09 | 26 | 126 | 7 | M39404 | |
| Pathway | WP_ESTROGEN_METABOLISM | 3.00e-08 | 22 | 126 | 6 | MM15888 | |
| Pathway | KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM | 6.73e-08 | 41 | 126 | 7 | M7399 | |
| Pathway | REACTOME_ASPIRIN_ADME | 1.32e-07 | 45 | 126 | 7 | MM15694 | |
| Pathway | KEGG_DRUG_METABOLISM_OTHER_ENZYMES | 3.22e-07 | 51 | 126 | 7 | M17726 | |
| Pathway | KEGG_STARCH_AND_SUCROSE_METABOLISM | 3.69e-07 | 52 | 126 | 7 | M14171 | |
| Pathway | WP_METAPATHWAY_BIOTRANSFORMATION | UGT1A10 UGT1A8 UGT1A7 UGT1A5 CYP19A1 CYP20A1 AKR1D1 UGT1A9 UGT1A4 UGT1A3 | 1.11e-06 | 153 | 126 | 10 | MM15844 |
| Pathway | KEGG_RETINOL_METABOLISM | 1.57e-06 | 64 | 126 | 7 | M9488 | |
| Pathway | REACTOME_ASPIRIN_ADME | 2.42e-06 | 44 | 126 | 6 | M45014 | |
| Pathway | KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450 | 2.90e-06 | 70 | 126 | 7 | M16794 | |
| Pathway | KEGG_DRUG_METABOLISM_CYTOCHROME_P450 | 3.51e-06 | 72 | 126 | 7 | M9257 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | AOC1 UGT1A10 UGT1A8 UGT1A7 UGT1A5 CYP19A1 UGT1A9 UGT1A4 UGT1A3 DPEP3 OPLAH | 4.21e-06 | 219 | 126 | 11 | MM14838 |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | AOC1 UGT1A10 UGT1A8 UGT1A7 UGT1A5 CYP19A1 UGT1A9 UGT1A4 UGT1A3 DPEP3 OPLAH | 4.40e-06 | 220 | 126 | 11 | M10320 |
| Pathway | REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS | 5.07e-06 | 107 | 126 | 8 | MM14595 | |
| Pathway | REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS | 5.82e-06 | 109 | 126 | 8 | M18788 | |
| Pathway | WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II | UGT1A10 UGT1A7 UGT1A5 CYP19A1 CYP20A1 AKR1D1 UGT1A9 UGT1A4 UGT1A3 | 3.84e-05 | 183 | 126 | 9 | M39588 |
| Pathway | WP_2Q37_COPY_NUMBER_VARIATION_SYNDROME | 4.67e-05 | 145 | 126 | 8 | M45512 | |
| Pathway | REACTOME_DRUG_ADME | 5.40e-05 | 109 | 126 | 7 | M45012 | |
| Pathway | REACTOME_METABOLISM_OF_CARBOHYDRATES | GALK1 BCAN XYLT2 NCAN RPEL1 CHPF2 GAPDHS FUT5 FUT6 RPE NUP160 | 5.42e-05 | 288 | 126 | 11 | M16864 |
| Pathway | REACTOME_DRUG_ADME | 9.43e-05 | 119 | 126 | 7 | MM15692 | |
| Pathway | WP_DISRUPTION_OF_POSTSYNAPTIC_SIGNALING_BY_CNV | 2.04e-04 | 33 | 126 | 4 | M39875 | |
| Pathway | WP_CODEINE_AND_MORPHINE_METABOLISM | 2.36e-04 | 14 | 126 | 3 | M39328 | |
| Pathway | REACTOME_ATORVASTATIN_ADME | 2.93e-04 | 15 | 126 | 3 | MM15697 | |
| Pathway | REACTOME_PARACETAMOL_ADME | 3.93e-04 | 39 | 126 | 4 | MM15695 | |
| Pathway | REACTOME_CHONDROITIN_SULFATE_BIOSYNTHESIS | 7.11e-04 | 20 | 126 | 3 | M658 | |
| Pathway | REACTOME_HEME_DEGRADATION | 7.11e-04 | 20 | 126 | 3 | MM14721 | |
| Pathway | KEGG_MEDICUS_REFERENCE_LEWIS_X_ANTIGEN_BIOSYNTHESIS | 7.79e-04 | 5 | 126 | 2 | M47966 | |
| Pathway | WP_TAMOXIFEN_METABOLISM | 8.24e-04 | 21 | 126 | 3 | M39631 | |
| Pathway | REACTOME_CHONDROITIN_SULFATE_DERMATAN_SULFATE_METABOLISM | 1.02e-03 | 50 | 126 | 4 | M678 | |
| Pathway | REACTOME_PREDNISONE_ADME | 1.08e-03 | 23 | 126 | 3 | MM16639 | |
| Pathway | WP_ARYLAMINE_METABOLISM | 1.16e-03 | 6 | 126 | 2 | M39437 | |
| Pathway | WP_NICOTINE_METABOLISM_IN_LIVER_CELLS | 1.16e-03 | 6 | 126 | 2 | M39600 | |
| Pathway | KEGG_MEDICUS_REFERENCE_SIALYL_LEWIS_X_ANTIGEN_BIOSYNTHESIS | 1.16e-03 | 6 | 126 | 2 | M47967 | |
| Pathway | WP_ESTROGEN_METABOLISM_WP5276 | 1.23e-03 | 24 | 126 | 3 | M46445 | |
| Pubmed | AOC1 ANPEP UGT1A10 UGT1A8 HEATR4 UGT1A7 UGT1A5 AKR1D1 SLC17A4 UGT1A9 UGT1A4 UGT1A3 NTAN1 SLC6A20 SHARPIN RPE OPLAH | 7.38e-17 | 190 | 169 | 17 | 24816252 | |
| Pubmed | 2.02e-15 | 9 | 169 | 7 | 22511988 | ||
| Pubmed | 6.69e-15 | 10 | 169 | 7 | 23642732 | ||
| Pubmed | 6.69e-15 | 10 | 169 | 7 | 11465080 | ||
| Pubmed | 6.69e-15 | 10 | 169 | 7 | 23371916 | ||
| Pubmed | A genome-wide association study of total bilirubin and cholelithiasis risk in sickle cell anemia. | 6.69e-15 | 10 | 169 | 7 | 22558097 | |
| Pubmed | 4.38e-14 | 12 | 169 | 7 | 19419973 | ||
| Pubmed | Thirteen UDPglucuronosyltransferase genes are encoded at the human UGT1 gene complex locus. | 4.38e-14 | 12 | 169 | 7 | 11434514 | |
| Pubmed | Assignment of the human UDP glucuronosyltransferase gene (UGT1A1) to chromosome region 2q37. | 8.39e-14 | 7 | 169 | 6 | 8467709 | |
| Pubmed | 8.39e-14 | 7 | 169 | 6 | 8464825 | ||
| Pubmed | UGT1A1 is a major locus influencing bilirubin levels in African Americans. | 9.45e-14 | 13 | 169 | 7 | 22085899 | |
| Pubmed | Genome-wide analysis of hepatic lipid content in extreme obesity. | 9.45e-14 | 13 | 169 | 7 | 25246029 | |
| Pubmed | 1.88e-13 | 14 | 169 | 7 | 21646302 | ||
| Pubmed | Human UDP-glucuronosyltransferases: metabolism, expression, and disease. | 1.88e-13 | 14 | 169 | 7 | 10836148 | |
| Pubmed | 1.88e-13 | 14 | 169 | 7 | 9295054 | ||
| Pubmed | Multiple variable first exons: a mechanism for cell- and tissue-specific gene regulation. | 1.88e-13 | 14 | 169 | 7 | 14672974 | |
| Pubmed | 3.34e-13 | 8 | 169 | 6 | 20610558 | ||
| Pubmed | 3.34e-13 | 8 | 169 | 6 | 17179145 | ||
| Pubmed | Genome-wide association meta-analysis for total serum bilirubin levels. | 6.22e-13 | 16 | 169 | 7 | 19414484 | |
| Pubmed | Genome-wide association of serum bilirubin levels in Korean population. | 1.05e-12 | 17 | 169 | 7 | 20639394 | |
| Pubmed | 2.55e-12 | 5 | 169 | 5 | 15057901 | ||
| Pubmed | A genome-wide assessment of variability in human serum metabolism. | 2.71e-12 | 19 | 169 | 7 | 23281178 | |
| Pubmed | Role of UDP-glucuronosyltransferase isoforms in 13-cis retinoic acid metabolism in humans. | 1.09e-11 | 12 | 169 | 6 | 20308471 | |
| Pubmed | Genetic determinants influencing human serum metabolome among African Americans. | 1.82e-11 | 24 | 169 | 7 | 24625756 | |
| Pubmed | 1.41e-10 | 8 | 169 | 5 | 18052087 | ||
| Pubmed | 3.17e-10 | 9 | 169 | 5 | 1339448 | ||
| Pubmed | Human metabolic individuality in biomedical and pharmaceutical research. | 3.55e-10 | 57 | 169 | 8 | 21886157 | |
| Pubmed | 5.38e-10 | 4 | 169 | 4 | 9271343 | ||
| Pubmed | 1.19e-09 | 66 | 169 | 8 | 19898482 | ||
| Pubmed | 8.01e-09 | 6 | 169 | 4 | 32527940 | ||
| Pubmed | Analysis of inherited genetic variations at the UGT1 locus in the French-Canadian population. | 8.01e-09 | 6 | 169 | 4 | 19204906 | |
| Pubmed | 8.01e-09 | 6 | 169 | 4 | 20297805 | ||
| Pubmed | 1.86e-08 | 7 | 169 | 4 | 27514509 | ||
| Pubmed | 2.08e-08 | 18 | 169 | 5 | 20056724 | ||
| Pubmed | Involvement of human UGT2B7 and 2B15 in rofecoxib metabolism. | 3.71e-08 | 8 | 169 | 4 | 12695355 | |
| Pubmed | 6.13e-08 | 108 | 169 | 8 | 19956635 | ||
| Pubmed | 1.13e-07 | 3 | 169 | 3 | 12847094 | ||
| Pubmed | 1.13e-07 | 3 | 169 | 3 | 29519853 | ||
| Pubmed | 3.92e-07 | 31 | 169 | 5 | 22282597 | ||
| Pubmed | Genetic variations and haplotypes of UDP-glucuronosyltransferase 1A locus in a Korean population. | 4.49e-07 | 4 | 169 | 3 | 18223459 | |
| Pubmed | 4.49e-07 | 4 | 169 | 3 | 9535849 | ||
| Pubmed | 4.49e-07 | 4 | 169 | 3 | 17558305 | ||
| Pubmed | Discovery and refinement of loci associated with lipid levels. | 1.01e-06 | 211 | 169 | 9 | 24097068 | |
| Pubmed | 1.12e-06 | 5 | 169 | 3 | 20565459 | ||
| Pubmed | Pharmacogenetics of antipsychotic response in the CATIE trial: a candidate gene analysis. | 1.89e-06 | 118 | 169 | 7 | 19156168 | |
| Pubmed | 2.23e-06 | 6 | 169 | 3 | 39142280 | ||
| Pubmed | 6.20e-06 | 8 | 169 | 3 | 22579593 | ||
| Pubmed | Genetic associations with schizophrenia: meta-analyses of 12 candidate genes. | 6.20e-06 | 8 | 169 | 3 | 18715757 | |
| Pubmed | Family-based genome-wide association scan of attention-deficit/hyperactivity disorder. | 9.27e-06 | 9 | 169 | 3 | 20732626 | |
| Pubmed | 1.81e-05 | 11 | 169 | 3 | 18695635 | ||
| Pubmed | Lower birth-weight in neonates of mothers carrying factor V G1691A and factor II A(20210) mutations. | 2.35e-05 | 2 | 169 | 2 | 11836168 | |
| Pubmed | Thrombophilic mutations are a main risk factor for placental abruption. | 2.35e-05 | 2 | 169 | 2 | 12857557 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 11183183 | ||
| Pubmed | Prevalence of factor V Leiden and prothrombin G20210A gene mutation. | 2.35e-05 | 2 | 169 | 2 | 15900364 | |
| Pubmed | Risk factors for catheter-related thrombosis in cancer patients. | 2.35e-05 | 2 | 169 | 2 | 15454250 | |
| Pubmed | Family history for venous thromboembolism and the risk for recurrence. | 2.35e-05 | 2 | 169 | 2 | 16431184 | |
| Pubmed | Prothrombotic gene mutations and Crohn's disease; is there any association? | 2.35e-05 | 2 | 169 | 2 | 16201098 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 16361766 | ||
| Pubmed | High incidence of factor V Leiden and prothrombin G20210A in healthy southern Italians. | 2.35e-05 | 2 | 169 | 2 | 19211580 | |
| Pubmed | Thrombophilic risk factors in epileptic children treated with valproic Acid. | 2.35e-05 | 2 | 169 | 2 | 19135623 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 16469858 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 16818854 | ||
| Pubmed | Are factor V and prothrombin mutations associated with increased risk of oral cancer? | 2.35e-05 | 2 | 169 | 2 | 16080493 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 22329698 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 33376137 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 8068691 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 18752569 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 11741359 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 21659542 | ||
| Pubmed | Thrombophilia differences in cerebral venous sinus and lower extremity deep venous thrombosis. | 2.35e-05 | 2 | 169 | 2 | 18285537 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 21259017 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 31501046 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 15947254 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 11694407 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 16446869 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 18462012 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 12725641 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 19404532 | ||
| Pubmed | Inherited thrombophilias and unexplained pregnancy loss: an incident case-control study. | 2.35e-05 | 2 | 169 | 2 | 19036071 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 18632446 | ||
| Pubmed | Association between thrombophilia gene polymorphisms and preeclampsia: a meta-analysis. | 2.35e-05 | 2 | 169 | 2 | 24967675 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 14504875 | ||
| Pubmed | Hormonal replacement therapy, prothrombotic mutations and the risk of venous thrombosis. | 2.35e-05 | 2 | 169 | 2 | 11886391 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 17439630 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 24282370 | ||
| Pubmed | Prothrombotic factors and the risk of acute onset non-cardioembolic stroke in young Asian Indians. | 2.35e-05 | 2 | 169 | 2 | 19560187 | |
| Pubmed | Inherited thrombophilic abnormalities and risk of portal vein thrombosis. a meta-analysis. | 2.35e-05 | 2 | 169 | 2 | 18392325 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 17067362 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 19620700 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 16006096 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 22210734 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 24641623 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 17890946 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 18983482 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 18983490 | ||
| Pubmed | Factor V Leiden and factor II G20210A in preeclampsia and HELLP syndrome. | 2.35e-05 | 2 | 169 | 2 | 12519104 | |
| Pubmed | Lack of association between hemorheological alterations and upper-extremity deep vein thrombosis. | 2.35e-05 | 2 | 169 | 2 | 19318721 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 14652651 | ||
| Pubmed | B7-DC (PD-L2) costimulation of CD4+ T-helper 1 response via RGMb. | 2.35e-05 | 2 | 169 | 2 | 28479601 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 20406709 | ||
| Cytoband | 2q37 | 1.97e-11 | 31 | 169 | 7 | 2q37 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q37 | 2.15e-06 | 226 | 169 | 8 | chr2q37 | |
| Cytoband | 2q36.2 | 4.03e-05 | 3 | 169 | 2 | 2q36.2 | |
| GeneFamily | UDP glucuronosyltransferases | 8.58e-10 | 32 | 112 | 7 | 363 | |
| GeneFamily | Immunoglobulin like domain containing | 3.18e-06 | 193 | 112 | 9 | 594 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | DPP4 IL13RA1 LILRA1 LILRA3 ANPEP CD3E NECTIN2 FCRL5 IL3RA FCAMR PDCD1LG2 | 3.35e-05 | 394 | 112 | 11 | 471 |
| GeneFamily | Fibronectin type III domain containing | 6.20e-05 | 160 | 112 | 7 | 555 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 2.26e-04 | 4 | 112 | 2 | 574 | |
| GeneFamily | Neuroblastoma breakpoint family | 3.74e-04 | 23 | 112 | 3 | 662 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 4.99e-04 | 161 | 112 | 6 | 593 | |
| GeneFamily | CD molecules|Activating leukocyte immunoglobulin like receptors | 5.61e-04 | 6 | 112 | 2 | 1181 | |
| GeneFamily | Glucosaminyl (N-acetyl) transferases/xylosyltransferases | 1.04e-03 | 8 | 112 | 2 | 441 | |
| GeneFamily | CD molecules|I-set domain containing|Immunoglobulin like domain containing|Interleukin receptors|TIR domain containing | 2.23e-03 | 42 | 112 | 3 | 602 | |
| GeneFamily | Fucosyltransferases|Blood group antigens | 2.84e-03 | 13 | 112 | 2 | 434 | |
| GeneFamily | Adenosine receptors|V-set domain containing | 3.46e-03 | 163 | 112 | 5 | 590 | |
| GeneFamily | Aminopeptidases|CD molecules | 4.87e-03 | 17 | 112 | 2 | 104 | |
| GeneFamily | Protein tyrosine phosphatases, receptor type | 7.40e-03 | 21 | 112 | 2 | 813 | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_macrophage-stroma-osteoclast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 6.02e-07 | 188 | 168 | 8 | 762b52f21d2bc5409f86746a904c4358490be9c0 | |
| ToppCell | E18.5-samps-Mesenchymal-Pericyte-pericyte_D|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.60e-06 | 149 | 168 | 7 | dcf68eb25733b5db2893728fe4dca5c7267eb58c | |
| ToppCell | Control-CD4+_T|World / Disease group and Cell class | 3.70e-06 | 169 | 168 | 7 | e330d85bd37a1bd1c3d8d29ddd8a2c1020a62a83 | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.40e-06 | 179 | 168 | 7 | 859cd8ee414ad6207c046ada2e655e49322dd01c | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular-Goblet-Goblet|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.61e-06 | 180 | 168 | 7 | 668a2d8e1d5a390309d5eb62c836f5903144bea9 | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular-Goblet|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.61e-06 | 180 | 168 | 7 | 3dc80bc636bf0e6ffc9762853132a9fe59fd1f66 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-large_intestine_goblet_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.25e-06 | 183 | 168 | 7 | 5a936fb07074cec753bf19e3e3e52499605ea22c | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-Goblet_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.25e-06 | 183 | 168 | 7 | 07c18ccc45ddc9c22e482bd9ffb87f46ebcfe473 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.47e-06 | 184 | 168 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.47e-06 | 184 | 168 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.47e-06 | 184 | 168 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar-Macro_c5-WDR74|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.71e-06 | 185 | 168 | 7 | 68edb1bb03ed221d49e583123ca4de14252d7bc5 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.45e-06 | 188 | 168 | 7 | 0501a8aa850bd2e347020abd1cac4d8075738189 | |
| ToppCell | Tracheal-10x3prime_v2-Epithelial-Epi_submucosal-gland|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 9.14e-06 | 194 | 168 | 7 | e90f6717e3421f8978d1fc1b2f30dcf69f6fcce7 | |
| ToppCell | LPS-IL1RA-Endothelial-Epi-like-Alv_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.42e-05 | 138 | 168 | 6 | 5f8ac8f67e34a7cf560099208e6884102532391e | |
| ToppCell | COVID-19-Fibroblasts-Mesothelial_FB|COVID-19 / group, cell type (main and fine annotations) | 1.60e-05 | 141 | 168 | 6 | 7e6dcccb74e7ee90b69dc91b59491b84f3a713c9 | |
| ToppCell | Control-Myeloid-MoAM1,_IL1R2|Control / Condition, Lineage and Cell class | 4.15e-05 | 167 | 168 | 6 | ab6029ba037b6a499da8758864c44e174cde5587 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Epithelial-epithelial_progenitor_cell|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.74e-05 | 171 | 168 | 6 | f2b31c97bbcc5164fc279ed0362007878887ad5e | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Epithelial-epithelial_progenitor_cell-Distal_progenitor|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.05e-05 | 173 | 168 | 6 | 81c36b9fe02c59099f080b2db02f4eaf2783911f | |
| ToppCell | PCW_13-14-Neuronal-Neuronal_SCP-neuro_SCP_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 5.22e-05 | 174 | 168 | 6 | 0d8e737860120dcd3a6b57992c612595904d585e | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_B-plasmablast-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 5.39e-05 | 175 | 168 | 6 | 89bf89466191da14896ed8928027f5b911436c22 | |
| ToppCell | 3'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial-LEC3_(ADGRG3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.56e-05 | 176 | 168 | 6 | 5d3b2395bb842eea39175f5af6a4c76527e2fc31 | |
| ToppCell | PCW_13-14-Neuronal-Neuronal_SCP|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 5.74e-05 | 177 | 168 | 6 | 621dd82f1393c961d4dd7a615aa52c9df9e36336 | |
| ToppCell | 10x5'-GI_large-bowel-Lymphocytic_T_CD4-Trm_Th1/Th17|GI_large-bowel / Manually curated celltypes from each tissue | 6.11e-05 | 179 | 168 | 6 | 6359f30005b17dc5b5c4c8f3a6a38c87ccfe4ee9 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2-Inh_L1-6_PVALB_SCUBE3_(Chandelier_1)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.49e-05 | 181 | 168 | 6 | 7704f236831cffe4f2a75d4c461eb88b4177e206 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l44-58|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.90e-05 | 183 | 168 | 6 | dc9602bed3136db91faeffef177006246dc92743 | |
| ToppCell | (7)_Epithelial-H_(AT1)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 7.11e-05 | 184 | 168 | 6 | 1f76b37c265b519171b767a52d48f31f0cdc4a3c | |
| ToppCell | facs-Large_Intestine-Distal-3m-Epithelial-large_intestine_goblet_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.55e-05 | 186 | 168 | 6 | 32d30f08b20a0a28e38b37bd52ab26d1d43736ce | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-interneuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.55e-05 | 186 | 168 | 6 | d1d01ce46e62944aa9864eda47e8401b5f0d2bdc | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_macrophage-stroma-osteoclast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 7.55e-05 | 186 | 168 | 6 | c9dfcf7bba7e5ef97ad5d9b7084fba932c91ab68 | |
| ToppCell | droplet-Lung-LUNG-1m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.77e-05 | 187 | 168 | 6 | 9c9ae8725905ba0cfe407878006ed06c2480fb72 | |
| ToppCell | droplet-Lung-LUNG-1m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.77e-05 | 187 | 168 | 6 | 9e9460e57cdc9cd0a0de2866b140e06d0bc19a8f | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.77e-05 | 187 | 168 | 6 | dcf6475ece5b34d9d58a0d1f51c18acedb19c119 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.77e-05 | 187 | 168 | 6 | f1356273bd3587b6883295edf15cb9cdb706c057 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-interneuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.77e-05 | 187 | 168 | 6 | 1b2fdbfb1ce3f19795dfc4b1da5a94f4b057ec41 | |
| ToppCell | Thalamus|World / BrainAtlas - Mouse McCarroll V32 | 7.85e-05 | 116 | 168 | 5 | 5ddfb2dd5459ff6d7ae38163a38eae64fda283b7 | |
| ToppCell | droplet-Lung-1m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.00e-05 | 188 | 168 | 6 | dc52dd2957be3f40001f0a56f3d9ac9d66ea466e | |
| ToppCell | droplet-Lung-1m-Endothelial-lymphatic_endothelial|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.00e-05 | 188 | 168 | 6 | 2ef08313087e91985bcffc46c3798470cdeec49c | |
| ToppCell | droplet-Lung-1m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.00e-05 | 188 | 168 | 6 | 1f1604b6dc0a8ad0be3d9aac0bef448459c22465 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.24e-05 | 189 | 168 | 6 | f0aaf2994d319a39877d2845eaab9f166adead4e | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.24e-05 | 189 | 168 | 6 | aadb7a2de4cbe7f0958651f2739bba430b93f5c1 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.24e-05 | 189 | 168 | 6 | f57200c93d39c9bce1adba0a6a1c178c028dd86b | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.24e-05 | 189 | 168 | 6 | 8977f3295b7df7c7474b3f371de90a82ae4bb50c | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.48e-05 | 190 | 168 | 6 | 3b8d1e66ae68c1eee64095e75195d76d97e24026 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.48e-05 | 190 | 168 | 6 | 56cc761e50fddfb5366391518b4d8e16589b6b42 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.48e-05 | 190 | 168 | 6 | 25d4b591f75c26e404a34c42f1742d580af6598d | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.48e-05 | 190 | 168 | 6 | dc655e4782aab274f0c9b6e36a5ce315e3a1a4b9 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.73e-05 | 191 | 168 | 6 | 7b386512284dfaa0e95358b28ee82632ee965e64 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.73e-05 | 191 | 168 | 6 | fa50a3c7ff86e1ee07100da1ace0b0fa1b0ab26b | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.25e-05 | 193 | 168 | 6 | 5fb7808dd971c1cc64c2bd4f8f1de646fb2d77f4 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.51e-05 | 194 | 168 | 6 | 02a9cc821c2b14aa7d0e55661a5fab66364474e1 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.51e-05 | 194 | 168 | 6 | 4f758718a1233c25c25d99fc1b7b06f906b8b0a2 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.79e-05 | 195 | 168 | 6 | 938b31dbf1674ee6fd0123bc88391ddcaf151217 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.79e-05 | 195 | 168 | 6 | d39e9e6544f49e677ebe528c6fe60b99a3630e30 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Monocytic-Classical_Monocyte-Mono_c1-CD14-CCL3|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.79e-05 | 195 | 168 | 6 | 9168267a799bbd4111b1227754ab8173ac1a4714 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-epithelial_progenitor_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.79e-05 | 195 | 168 | 6 | 702dc7397c4a3ee50bb97ca24b9ab0d9b07fec9b | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.01e-04 | 196 | 168 | 6 | 7af6c5147ac859353504d19727dbe24f63a29dd4 | |
| ToppCell | Sepsis-URO-Lymphocyte-T/NK-Treg|URO / Disease, condition lineage and cell class | 1.01e-04 | 196 | 168 | 6 | 8812d7365fb2b33feff93782d60776e932499a43 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW08-Neuronal-GABAergic_neurons|GW08 / Sample Type, Dataset, Time_group, and Cell type. | 1.03e-04 | 197 | 168 | 6 | e1a80c1aa7f7e83f5d19a40fe37db5c5a6c25685 | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Myeloid-Macrophage_other-Macro_interstitial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.03e-04 | 197 | 168 | 6 | 780ab4a9f1dbf1f58b70a716ba2949c4f51b9295 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Epithelial-epithelial_progenitor_cell|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.03e-04 | 197 | 168 | 6 | f097e729f515e7945b9482e9f9dbc9536b90f0bb | |
| ToppCell | Bronchial-10x5prime-Stromal-Mesofibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.03e-04 | 197 | 168 | 6 | 438de7f0d35d81d5f5e41dcef7b2c54b6da03df4 | |
| ToppCell | Tracheal-10x5prime-Stromal-Schwann-Schwann_nonmyelinating|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.03e-04 | 197 | 168 | 6 | e239caae24f40564a24ad909754f5436f767ccdb | |
| ToppCell | Bronchial-10x5prime-Stromal-Mesofibroblastic-Mesothelia|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.03e-04 | 197 | 168 | 6 | 26888af95a7cc082a1f1218af35b1f07cb9436ed | |
| ToppCell | 3'_v3-GI_small-bowel-Myeloid_Monocytic|GI_small-bowel / Manually curated celltypes from each tissue | 1.03e-04 | 197 | 168 | 6 | dcf0009057576a7db9065e644a3919d6de2ac8e6 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.06e-04 | 198 | 168 | 6 | e125eb8aa57c172e5518874da1bd25998292f5e2 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_alveolar-Macro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.06e-04 | 198 | 168 | 6 | 0baeb8e2c199ff10bb5c829c523546af3c9227c1 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Monocytic-Classical_Monocyte|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.06e-04 | 198 | 168 | 6 | 94e2567f057b2c455a9656b121321a28e7cb1d2b | |
| ToppCell | Parenchyma_COVID-19-Immune-TX-MoAM-4|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 1.06e-04 | 198 | 168 | 6 | a7eed9eeb728a8796e2780090cc244856efd8c65 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Monocytic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.06e-04 | 198 | 168 | 6 | f3a12a7e23bb4ff6e82fee675dbc090d99587f69 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-epithelial_progenitor_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.09e-04 | 199 | 168 | 6 | 416ea20b49a48bf47ec3abfbe707e4d1254e2f88 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.12e-04 | 200 | 168 | 6 | bcd1cc96197929d6011903803b6f4ccdcf52b4ce | |
| ToppCell | Sigmoid-(4)_Monocyte|Sigmoid / shred on region, Cell_type, and subtype | 1.12e-04 | 200 | 168 | 6 | 7f3920a0434d5199c6c8f0b3064a305bb0d87b60 | |
| ToppCell | Sigmoid-Monocyte-Monocyte|Sigmoid / Region, Cell class and subclass | 1.12e-04 | 200 | 168 | 6 | 010ca36970cb8894bdbca08779c0ecf56be22fc9 | |
| ToppCell | Sigmoid-Monocyte|Sigmoid / Region, Cell class and subclass | 1.12e-04 | 200 | 168 | 6 | c41bd6ec0f2262fce5cadb37a400d487e6662f49 | |
| ToppCell | Sigmoid-(4)_Monocyte-(40)_Monocyte|Sigmoid / shred on region, Cell_type, and subtype | 1.12e-04 | 200 | 168 | 6 | 576c0a1098e6a934448705de3673ef798fcf1b26 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-NMBR-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.12e-04 | 200 | 168 | 6 | d416a7be1a4e6232fb58a9687774da24821f1fdd | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-SCUBE3--L2-5|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.12e-04 | 200 | 168 | 6 | d841dbe2297c3bf62f49bae5921662cd6a47e5c2 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-SCUBE3|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.12e-04 | 200 | 168 | 6 | 2441a36d363b799a4692aa697f969cda056c2d60 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-NMBR|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.12e-04 | 200 | 168 | 6 | 862db57d043bdf3cb059fbfc8b29bc1eafdf64ec | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-NMBR--L1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.12e-04 | 200 | 168 | 6 | a91345f268f13170c27309333603eb82400c9947 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-SCUBE3-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.12e-04 | 200 | 168 | 6 | c7bca638229bd4fd2414171e73fa949e36a10a92 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Schwann-Schwann_nonmyelinating|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.49e-04 | 133 | 168 | 5 | b4e68a9a223e5188f1a00c7dc9bb2d675cde1d40 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Schwann|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.49e-04 | 133 | 168 | 5 | 8819fd897b97812355e1709fcc42754522d5fb27 | |
| Drug | AC1MRQNQ | 3.58e-14 | 9 | 167 | 7 | CID003522271 | |
| Drug | DHPASiU | 3.58e-14 | 9 | 167 | 7 | CID000197602 | |
| Drug | 3-iodophenol | 3.58e-14 | 9 | 167 | 7 | CID000012272 | |
| Drug | AC1L4J7U | 3.58e-14 | 9 | 167 | 7 | CID000186631 | |
| Drug | Chebi:32663 | 3.58e-14 | 9 | 167 | 7 | CID005460873 | |
| Drug | 4-nitrophenyl)imidazole | 3.24e-13 | 11 | 167 | 7 | CID000123155 | |
| Drug | AC1O5XMV | 3.24e-13 | 11 | 167 | 7 | CID006442661 | |
| Drug | N-OH-DABZ | 7.73e-13 | 12 | 167 | 7 | CID000051366 | |
| Drug | 1-O-beta-D-glucopyranosyl-D-mannitol | 7.73e-13 | 12 | 167 | 7 | CID000088735 | |
| Drug | 2,4,6-TCB | 7.73e-13 | 12 | 167 | 7 | CID000037247 | |
| Drug | nonanoyl-N-methylglucamide | 7.73e-13 | 12 | 167 | 7 | CID000160090 | |
| Drug | 7,7,7-triphenylheptanoic acid | 7.73e-13 | 12 | 167 | 7 | CID000276709 | |
| Drug | indole-2-carboxylic acid | UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 GRIN2C UGT1A4 UGT1A3 PLIN3 | 1.20e-12 | 32 | 167 | 9 | CID000072899 |
| Drug | tritanol | 1.66e-12 | 13 | 167 | 7 | CID000006457 | |
| Drug | 5-azido-UDP-glucuronic acid | 1.66e-12 | 13 | 167 | 7 | CID003081279 | |
| Drug | cotinine-N-glucuronide | 1.66e-12 | 13 | 167 | 7 | CID000000411 | |
| Drug | propranolol glucuronide | 3.31e-12 | 14 | 167 | 7 | CID000119515 | |
| Drug | PCB-61 | 3.31e-12 | 14 | 167 | 7 | CID000036401 | |
| Drug | 2,2',3,5,5'-pentachlorobiphenyl | 6.16e-12 | 15 | 167 | 7 | CID000040469 | |
| Drug | afloqualone | 6.16e-12 | 15 | 167 | 7 | CID000002040 | |
| Drug | naphthyl sulphate | 6.16e-12 | 15 | 167 | 7 | CID000114775 | |
| Drug | coumarin-3-carboxylic acid | 6.16e-12 | 15 | 167 | 7 | CID000010752 | |
| Drug | sulforaphane nitrile | 6.16e-12 | 15 | 167 | 7 | CID000543743 | |
| Drug | quercetin-3,4'-diglucoside | 1.09e-11 | 16 | 167 | 7 | CID005320835 | |
| Drug | 1'-hydroxyestragole | 1.09e-11 | 16 | 167 | 7 | CID000040003 | |
| Drug | bilirubin-phosphate | 1.09e-11 | 16 | 167 | 7 | CID005497144 | |
| Drug | 3 beta,5 alpha,25R)- 3-hydroxyspirostan-12-one | 1.84e-11 | 17 | 167 | 7 | CID000003573 | |
| Drug | 6-hydroxychrysene | 1.84e-11 | 17 | 167 | 7 | CID000037766 | |
| Drug | CARMINE | 1.94e-11 | 28 | 167 | 8 | CID000014749 | |
| Drug | trans-3'-hydroxycotinine | 2.66e-11 | 29 | 167 | 8 | CID000000414 | |
| Drug | SureCN12722713 | 2.99e-11 | 18 | 167 | 7 | CID005488034 | |
| Drug | ethyl-beta-D-6-glucosiduronic acid | 2.99e-11 | 18 | 167 | 7 | CID000152226 | |
| Drug | Br 2 | 2.99e-11 | 18 | 167 | 7 | CID003060900 | |
| Drug | 2,3,7-trichlorodibenzo-p-dioxin | 2.99e-11 | 18 | 167 | 7 | CID000036614 | |
| Drug | ApApG | 2.99e-11 | 18 | 167 | 7 | CID003081975 | |
| Drug | C1 11-32 | 2.99e-11 | 18 | 167 | 7 | CID000443077 | |
| Drug | C11131 | 2.99e-11 | 18 | 167 | 7 | CID000443076 | |
| Drug | 9-OH-risperidone | 4.71e-11 | 19 | 167 | 7 | CID000475100 | |
| Drug | 5alpha-spirostan-3beta-ol | 4.71e-11 | 19 | 167 | 7 | CID000091433 | |
| Drug | almokalant | 4.71e-11 | 19 | 167 | 7 | CID003033962 | |
| Drug | tectochrysin | 7.20e-11 | 20 | 167 | 7 | CID005281954 | |
| Drug | AC1L1OBF | 7.20e-11 | 20 | 167 | 7 | CID000032736 | |
| Drug | 4'-hydroxydiclofenac | 7.20e-11 | 20 | 167 | 7 | CID000116545 | |
| Drug | R(-)-Denopamine | 8.41e-11 | 33 | 167 | 8 | CID000003818 | |
| Drug | norbuprenorphine | 8.41e-11 | 33 | 167 | 8 | CID000114976 | |
| Drug | estriol-16-glucuronide | 1.07e-10 | 21 | 167 | 7 | CID000122281 | |
| Drug | dulcin | 1.07e-10 | 21 | 167 | 7 | CID000009013 | |
| Drug | Benzamidoxime hydrochloride | 1.07e-10 | 21 | 167 | 7 | CID000069186 | |
| Drug | Finrazole | GABRB2 UGT1A10 UGT1A8 UGT1A7 UGT1A5 CYP19A1 UGT1A9 UGT1A4 UGT1A3 | 1.16e-10 | 51 | 167 | 9 | CID000178036 |
| Drug | amonafide | 1.56e-10 | 22 | 167 | 7 | CID000050515 | |
| Drug | N-methylpiperazine | 1.56e-10 | 22 | 167 | 7 | CID000053167 | |
| Drug | muraglitazar | 1.80e-10 | 36 | 167 | 8 | CID000206044 | |
| Drug | amidoxime | 2.24e-10 | 23 | 167 | 7 | CID000465967 | |
| Drug | estradiol-3-glucuronide | 2.24e-10 | 23 | 167 | 7 | CID000066651 | |
| Drug | phenanthridine | 2.24e-10 | 23 | 167 | 7 | CID000009189 | |
| Drug | 6beta-hydroxytestosterone | 2.28e-10 | 37 | 167 | 8 | CID000065543 | |
| Drug | AC1Q6OQF | UGT1A10 UGT1A8 UGT1A7 UGT1A5 CYP19A1 UGT1A9 UGT1A4 UGT1A3 CPNE1 | 2.36e-10 | 55 | 167 | 9 | CID000009685 |
| Drug | AS-3201 | 3.14e-10 | 24 | 167 | 7 | CID000153948 | |
| Drug | 5-MOP | 4.33e-10 | 25 | 167 | 7 | CID000002355 | |
| Drug | AzMC | 4.33e-10 | 25 | 167 | 7 | CID000064986 | |
| Drug | N-acetylbenzidine | 4.33e-10 | 25 | 167 | 7 | CID000018787 | |
| Drug | 5,6-benzoquinoline | 4.33e-10 | 25 | 167 | 7 | CID000006796 | |
| Drug | N-phenylmaleimide | 4.33e-10 | 25 | 167 | 7 | CID000013662 | |
| Drug | thymoquinone | 4.46e-10 | 40 | 167 | 8 | CID000010281 | |
| Drug | buprenorphine hydrochloride solution | 5.50e-10 | 41 | 167 | 8 | CID000002476 | |
| Drug | testosterone glucuronide | 5.50e-10 | 41 | 167 | 8 | CID000108192 | |
| Drug | AC1Q6O8B | 5.50e-10 | 41 | 167 | 8 | CID000000334 | |
| Drug | AC1NFJIQ | 6.76e-10 | 42 | 167 | 8 | CID004659568 | |
| Drug | diflunisal | 7.90e-10 | 27 | 167 | 7 | CID000003059 | |
| Drug | DiMeIQx | 7.90e-10 | 27 | 167 | 7 | CID000104739 | |
| Drug | erucin | 1.05e-09 | 28 | 167 | 7 | CID000078160 | |
| Drug | N-hydroxy-4-aminobiphenyl | 1.05e-09 | 28 | 167 | 7 | CID000081261 | |
| Drug | H-Ni | 1.05e-09 | 28 | 167 | 7 | CID000445665 | |
| Drug | AC1L1JAL | 1.37e-09 | 29 | 167 | 7 | CID000004954 | |
| Drug | 7-hydroxycoumarin glucuronide | 1.37e-09 | 29 | 167 | 7 | CID000125641 | |
| Drug | 7-hydroxy-4-trifluoromethylcoumarin | 1.37e-09 | 29 | 167 | 7 | CID005375667 | |
| Drug | iberin | 1.37e-09 | 29 | 167 | 7 | CID000010455 | |
| Drug | tolcapone | 1.78e-09 | 30 | 167 | 7 | CID004659569 | |
| Drug | paricalcitol | 1.78e-09 | 30 | 167 | 7 | CID005281104 | |
| Drug | AC1L9E0Q | 1.78e-09 | 30 | 167 | 7 | CID000443095 | |
| Drug | dihydroartemisinin | 1.78e-09 | 30 | 167 | 7 | CID000107770 | |
| Drug | isoamyl alcohol | 2.08e-09 | 48 | 167 | 8 | CID000031260 | |
| Drug | niflumic acid | UGT1A10 UGT1A8 UGT1A7 UGT1A5 CYP19A1 UGT1A9 F2 UGT1A4 UGT1A3 KCNMA1 SMPD1 | 2.14e-09 | 125 | 167 | 11 | CID000004488 |
| Drug | PCB 156 | 2.28e-09 | 31 | 167 | 7 | CID000038019 | |
| Drug | 4'-HPPH | 2.28e-09 | 31 | 167 | 7 | CID000017732 | |
| Drug | 4-ethylphenol | 2.28e-09 | 31 | 167 | 7 | CID000031242 | |
| Drug | AC1L1G0K | 2.47e-09 | 49 | 167 | 8 | CID000003473 | |
| Drug | EM-652 | 2.47e-09 | 49 | 167 | 8 | CID000155435 | |
| Drug | levo-dromoran tartrate | UGT1A10 UGT1A8 UGT1A7 UGT1A5 CYP19A1 UGT1A9 GRIN2C GRM1 UGT1A4 UGT1A3 | 2.76e-09 | 98 | 167 | 10 | CID000003918 |
| Drug | hydratropic acid | 2.79e-09 | 4 | 167 | 4 | ctd:C013025 | |
| Drug | 2-vanillin | 2.79e-09 | 4 | 167 | 4 | ctd:C060843 | |
| Drug | diphenylacetic acid | 2.79e-09 | 4 | 167 | 4 | ctd:C037760 | |
| Drug | Muracein C | 2.90e-09 | 32 | 167 | 7 | CID003086323 | |
| Drug | NNAL | 2.90e-09 | 32 | 167 | 7 | CID000104856 | |
| Drug | p,p'-hydroxy-DDT | 2.92e-09 | 50 | 167 | 8 | CID000076302 | |
| Drug | scopoletin | 2.92e-09 | 50 | 167 | 8 | CID005280460 | |
| Drug | C2-MPAcid | 3.45e-09 | 51 | 167 | 8 | CID000508230 | |
| Drug | AC1Q6OQG | 3.66e-09 | 33 | 167 | 7 | CID000009686 | |
| Drug | 6-methylsalicylic acid | 3.66e-09 | 33 | 167 | 7 | CID000011279 | |
| Drug | BP-3,6-quinol | 3.66e-09 | 33 | 167 | 7 | CID000119292 | |
| Disease | retinol dehydrogenase 16 measurement | 6.75e-16 | 13 | 157 | 8 | EFO_0802007 | |
| Disease | X-11793--oxidized bilirubin measurement | 8.40e-16 | 8 | 157 | 7 | EFO_0021260 | |
| Disease | Succinimide measurement | 8.40e-16 | 8 | 157 | 7 | EFO_0022118 | |
| Disease | X-11530 measurement | 8.40e-16 | 8 | 157 | 7 | EFO_0021249 | |
| Disease | sulfate of piperine metabolite C16H19NO3 (2) measurement | 8.40e-16 | 8 | 157 | 7 | EFO_0801034 | |
| Disease | cholelithiasis, bilirubin measurement | 8.40e-16 | 8 | 157 | 7 | EFO_0004570, EFO_0004799 | |
| Disease | X-11522 measurement | 8.40e-16 | 8 | 157 | 7 | EFO_0800696 | |
| Disease | X-10458 measurement | 8.40e-16 | 8 | 157 | 7 | EFO_0800692 | |
| Disease | X-24849 measurement | 8.40e-16 | 8 | 157 | 7 | EFO_0800909 | |
| Disease | membrane-associated progesterone receptor component 1 measurement | 8.40e-16 | 8 | 157 | 7 | EFO_0802740 | |
| Disease | X-16946 measurement | 8.40e-16 | 8 | 157 | 7 | EFO_0800766 | |
| Disease | X-11442 measurement | 3.76e-15 | 9 | 157 | 7 | EFO_0021236 | |
| Disease | X-11441 measurement | 3.76e-15 | 9 | 157 | 7 | EFO_0021235 | |
| Disease | circulating cell free DNA measurement | 3.76e-15 | 9 | 157 | 7 | EFO_0004739 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (3) measurement | 3.76e-15 | 9 | 157 | 7 | EFO_0801037 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (1) measurement | 3.76e-15 | 9 | 157 | 7 | EFO_0801036 | |
| Disease | X-11880 measurement | 3.76e-15 | 9 | 157 | 7 | EFO_0800698 | |
| Disease | protein-tyrosine kinase 6 measurement | 3.76e-15 | 9 | 157 | 7 | EFO_0020691 | |
| Disease | testis-specific chromodomain protein Y 1 measurement | 3.76e-15 | 9 | 157 | 7 | EFO_0802127 | |
| Disease | bilirubin measurement, response to xenobiotic stimulus | 3.76e-15 | 9 | 157 | 7 | EFO_0004570, GO_0009410 | |
| Disease | bilirubin measurement, response to tenofovir | 1.25e-14 | 10 | 157 | 7 | EFO_0004570, EFO_0009279 | |
| Disease | X-21448 measurement | 1.25e-14 | 10 | 157 | 7 | EFO_0800816 | |
| Disease | UDP-glucuronosyltransferase 1-6 measurement | 1.25e-14 | 10 | 157 | 7 | EFO_0802185 | |
| Disease | X-23974 measurement | 1.25e-14 | 10 | 157 | 7 | EFO_0800867 | |
| Disease | histidine betaine (hercynine) measurement | 3.42e-14 | 11 | 157 | 7 | EFO_0800972 | |
| Disease | X-21796 measurement | 3.42e-14 | 11 | 157 | 7 | EFO_0800825 | |
| Disease | insomnia, bilirubin measurement | 3.42e-14 | 11 | 157 | 7 | EFO_0004570, EFO_0004698 | |
| Disease | aldosterone measurement | 3.42e-14 | 11 | 157 | 7 | EFO_0010219 | |
| Disease | p-cresol glucuronide measurement | 8.17e-14 | 12 | 157 | 7 | EFO_0800079 | |
| Disease | biliverdin measurement | 8.17e-14 | 12 | 157 | 7 | EFO_0021033 | |
| Disease | low density lipoprotein cholesterol measurement, body fat percentage | 1.96e-12 | 17 | 157 | 7 | EFO_0004611, EFO_0007800 | |
| Disease | xanthurenate measurement | 2.09e-12 | 29 | 157 | 8 | EFO_0010551 | |
| Disease | angiopoietin-related protein 1 measurement | 3.20e-12 | 18 | 157 | 7 | EFO_0801382 | |
| Disease | pregnenetriol sulfate measurement | 9.31e-12 | 11 | 157 | 6 | EFO_0800586 | |
| Disease | plasma N-desmethylclozapine measurement | 9.31e-12 | 11 | 157 | 6 | EFO_0600039 | |
| Disease | tissue factor measurement | 1.15e-11 | 21 | 157 | 7 | EFO_0010623 | |
| Disease | pregnenetriol disulfate measurement | 3.43e-11 | 13 | 157 | 6 | EFO_0800587 | |
| Disease | response to dolutegravir | 1.94e-10 | 30 | 157 | 7 | EFO_0600017 | |
| Disease | serum N-desmethylclozapine measurement | 2.21e-10 | 8 | 157 | 5 | EFO_0600043 | |
| Disease | plasma clozapine measurement | 2.21e-10 | 8 | 157 | 5 | EFO_0600038 | |
| Disease | X-21441 measurement | 2.43e-10 | 17 | 157 | 6 | EFO_0800814 | |
| Disease | metabolite measurement | AOC1 UGT1A10 UGT1A8 HEATR4 UGT1A7 UGT1A5 PIWIL1 AKR1D1 SLC17A4 UGT1A9 ITPR2 UGT1A4 TUBGCP6 UGT1A3 SLC7A6OS SLC6A20 RIMBP2 FUT6 | 1.29e-09 | 560 | 157 | 18 | EFO_0004725 |
| Disease | N-acetyl-4-chlorophenylalanine measurement | 3.84e-09 | 5 | 157 | 4 | EFO_0801060 | |
| Disease | 5-hydroxyindole sulfate measurement | 3.84e-09 | 5 | 157 | 4 | EFO_0800085 | |
| Disease | nuclear receptor subfamily 1 group D member 2 measurement | 3.84e-09 | 5 | 157 | 4 | EFO_0801853 | |
| Disease | gallstones | ANPEP UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 UGT1A4 UGT1A3 FUT6 | 6.77e-09 | 108 | 157 | 9 | EFO_0004210 |
| Disease | thyroxine measurement | 1.51e-08 | 83 | 157 | 8 | EFO_0005130 | |
| Disease | cholelithiasis | 2.41e-08 | 88 | 157 | 8 | EFO_0004799 | |
| Disease | urate measurement, spine bone mineral density | 2.53e-08 | 58 | 157 | 7 | EFO_0004531, EFO_0007701 | |
| Disease | X-21339 measurement | 2.67e-08 | 7 | 157 | 4 | EFO_0800808 | |
| Disease | Schizophrenia | GABRB2 RELN DRD4 DAO CHEK1 GRIN2C PLEKHA6 GRM1 F2 CHRNA5 SYNGAP1 UGT1A3 NTNG2 NRXN3 TRMT2A NCAN DIO3 DIXDC1 IL3RA SLC17A6 | 5.44e-08 | 883 | 157 | 20 | C0036341 |
| Disease | indole-3-carboxylate measurement | 1.48e-07 | 3 | 157 | 3 | EFO_0800043 | |
| Disease | blood 4-oxo-retinoic acid measurement | 1.48e-07 | 3 | 157 | 3 | EFO_0022216 | |
| Disease | vitamin D measurement, COVID-19 | 2.39e-07 | 49 | 157 | 6 | EFO_0004631, MONDO_0100096 | |
| Disease | hormone measurement | 3.39e-07 | 84 | 157 | 7 | EFO_0004730 | |
| Disease | X-24588 measurement | 5.31e-07 | 13 | 157 | 4 | EFO_0800898 | |
| Disease | serum metabolite measurement | PCYT1A AOC1 UGT1A10 UGT1A8 HEATR4 UGT1A7 UGT1A5 UGT1A9 ERMP1 UGT1A4 UGT1A3 NTAN1 PTPRH SLC7A6OS NECTIN2 MYOM2 FCRL5 RPE OPLAH | 7.31e-07 | 945 | 157 | 19 | EFO_0005653 |
| Disease | free androgen index | PCYT1A UGT1A10 UGT1A8 UGT1A7 UGT1A5 CYP19A1 AKR1D1 UGT1A9 UGT1A4 UBE2E2 RIMBP2 NUP160 | 8.45e-07 | 374 | 157 | 12 | EFO_0007005 |
| Disease | vitamin D deficiency | 1.52e-06 | 37 | 157 | 5 | EFO_0003762 | |
| Disease | 3-carboxy-4-methyl-5-pentyl-2-furanpropionate (3-CMPFP) measurement | 2.92e-06 | 6 | 157 | 3 | EFO_0800566 | |
| Disease | neuroblastoma, cutaneous melanoma | 1.43e-05 | 28 | 157 | 4 | EFO_0000389, EFO_0000621 | |
| Disease | indoleacetate measurement | 1.73e-05 | 10 | 157 | 3 | EFO_0021015 | |
| Disease | Mesenteric Venous Thrombosis | 2.81e-05 | 2 | 157 | 2 | C0267412 | |
| Disease | Occlusive Mesenteric Arterial Ischemia | 2.81e-05 | 2 | 157 | 2 | C3852985 | |
| Disease | Acute Mesenteric Arterial Embolus | 2.81e-05 | 2 | 157 | 2 | C3852984 | |
| Disease | Acute Mesenteric Arterial Thrombosis | 2.81e-05 | 2 | 157 | 2 | C3852987 | |
| Disease | Nonocclusive Mesenteric Ischemia | 2.81e-05 | 2 | 157 | 2 | C3852986 | |
| Disease | Mesenteric vascular insufficiency | 2.81e-05 | 2 | 157 | 2 | C1412000 | |
| Disease | 5-oxoproline measurement | 7.87e-05 | 16 | 157 | 3 | EFO_0010988 | |
| Disease | Brown-Vialetto-Van Laere syndrome (implicated_via_orthology) | 8.41e-05 | 3 | 157 | 2 | DOID:0050694 (implicated_via_orthology) | |
| Disease | bilirubin measurement | UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 UGT1A4 UGT1A3 NECTIN2 DMBT1 IL27 | 1.36e-04 | 442 | 157 | 10 | EFO_0004570 |
| Disease | alpha-(1;3)-fucosyltransferase 5 measurement | 1.68e-04 | 4 | 157 | 2 | EFO_0021979 | |
| Disease | X-24020 measurement | 2.78e-04 | 5 | 157 | 2 | EFO_0022128 | |
| Disease | Wilson disease (implicated_via_orthology) | 2.78e-04 | 5 | 157 | 2 | DOID:893 (implicated_via_orthology) | |
| Disease | pulmonary embolism (is_implicated_in) | 2.78e-04 | 5 | 157 | 2 | DOID:9477 (is_implicated_in) | |
| Disease | STROKE, ISCHEMIC | 2.78e-04 | 5 | 157 | 2 | 601367 | |
| Disease | Ischemic stroke | 2.78e-04 | 5 | 157 | 2 | cv:C0948008 | |
| Disease | Depressive Symptoms | 3.51e-04 | 26 | 157 | 3 | C0086132 | |
| Disease | interleukin-27 measurement | 4.16e-04 | 6 | 157 | 2 | EFO_0010916 | |
| Disease | Myofibrillar myopathy | 4.16e-04 | 6 | 157 | 2 | cv:C2678065 | |
| Disease | Liver Failure | 4.16e-04 | 6 | 157 | 2 | C0085605 | |
| Disease | testosterone measurement | PCYT1A NRDE2 AOC1 DCDC1 UGT1A10 UGT1A8 UGT1A7 UGT1A5 CYP19A1 AKR1D1 UGT1A9 DAO UGT1A4 NTNG2 UBE2E2 RIMBP2 NUP160 | 4.70e-04 | 1275 | 157 | 17 | EFO_0004908 |
| Disease | Unipolar Depression | 4.93e-04 | 259 | 157 | 7 | C0041696 | |
| Disease | urate measurement, bone density | UGT1A10 LINC02898 UGT1A8 UGT1A7 UGT1A9 QRICH1 GRIN2C ITPR2 RANBP17 KCNMA1 DMBT1 | 5.02e-04 | 619 | 157 | 11 | EFO_0003923, EFO_0004531 |
| Disease | Autistic Disorder | 5.16e-04 | 261 | 157 | 7 | C0004352 | |
| Disease | Manic Disorder | 5.68e-04 | 71 | 157 | 4 | C0024713 | |
| Disease | lithostathine-1-alpha measurement | 5.80e-04 | 7 | 157 | 2 | EFO_0801083 | |
| Disease | acisoga measurement | 5.80e-04 | 7 | 157 | 2 | EFO_0800068 | |
| Disease | galactoside 3(4)-L-fucosyltransferase measurement | 5.80e-04 | 7 | 157 | 2 | EFO_0021853 | |
| Disease | retinal vein occlusion (is_implicated_in) | 5.80e-04 | 7 | 157 | 2 | DOID:1727 (is_implicated_in) | |
| Disease | alpha-(1,3)-fucosyltransferase 5 measurement | 5.80e-04 | 7 | 157 | 2 | EFO_0020136 | |
| Disease | Malignant neoplasm of breast | THEMIS2 COL7A1 ATP7B CYP19A1 UGT1A9 MANEA CHEK1 TTC3 TRMT2A NFKBIA NECTIN2 TENM1 DIO3 FCRL5 SLC17A6 | 6.39e-04 | 1074 | 157 | 15 | C0006142 |
| Disease | stachydrine measurement | 7.71e-04 | 8 | 157 | 2 | EFO_0021169 | |
| Disease | Thrombophilia due to thrombin defect | 7.71e-04 | 8 | 157 | 2 | cv:C3160733 | |
| Disease | Venous Thromboembolism | 7.71e-04 | 8 | 157 | 2 | C1861172 | |
| Disease | renin measurement | 7.71e-04 | 8 | 157 | 2 | EFO_0010616 | |
| Disease | Manic | 8.10e-04 | 78 | 157 | 4 | C0338831 | |
| Disease | Depression, Bipolar | 8.50e-04 | 79 | 157 | 4 | C0005587 | |
| Disease | apolipoprotein B measurement | GALK1 UGT1A10 UGT1A8 UGT1A7 UGT1A5 CYP20A1 UGT1A9 UGT1A4 UGT1A3 NCAN NECTIN2 | 8.81e-04 | 663 | 157 | 11 | EFO_0004615 |
| Disease | Cardiomegaly | 9.77e-04 | 82 | 157 | 4 | C0018800 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| APERDPVGSWYNVTI | 161 | Q5DID0 | |
| PQTVLWRYTGTRPSN | 331 | P35503 | |
| PRTGLSLWDTSPSYI | 321 | O14757 | |
| ITAYSPLGTSRNPIW | 216 | P51857 | |
| ARETYGLPNTLPTAW | 541 | P17405 | |
| RDSPRATPWDQVSYV | 1411 | P35670 | |
| TQVGSEYRESWPPNS | 571 | Q155Q3 | |
| RVYIGSFWSQPLLVP | 251 | Q9NZN4 | |
| ITDVWGPSISYPRKV | 841 | Q5XX13 | |
| VWIPSPASRSYLLSV | 231 | Q96L96 | |
| YRPAQVTWSQLPEVV | 256 | Q5VV41 | |
| LAYWPGRVPVNVTST | 346 | Q96EG1 | |
| RPSEFNYVWIVPITS | 576 | P15144 | |
| VNRISYWPADPEISL | 146 | Q9BWV3 | |
| RPGYQSSWASRPIST | 131 | P19801 | |
| TVAVVLPLANTSYPW | 36 | P16066 | |
| QVTIPPVLLGYTWSN | 1021 | Q6DHV5 | |
| TGPENPWLVQAYVSA | 291 | Q7Z2K6 | |
| YISWLQSRINIPIGP | 531 | Q8IWA6 | |
| VERWYGEPTCTTPIL | 756 | Q9H2T7 | |
| TGYPLAEVSWPNVSV | 146 | Q9BQ51 | |
| GETWTIPVYSAQPRG | 306 | Q2TAL8 | |
| PQESVVPVRYARLWT | 791 | Q14571 | |
| PLTTTDVAAGLWQPY | 41 | P14920 | |
| SKEWISVSPLPRGIY | 431 | Q8NAB2 | |
| GWLSDQTVRYPIQTP | 206 | Q96GW7 | |
| ARALYTPSGEPIQSW | 1706 | M0R2J8 | |
| TWSPSQISGLPTRYL | 131 | Q14626 | |
| TWITDITLPRFQVGP | 6 | Q96R47 | |
| EYPPTQDGRTAAWRT | 136 | P50579 | |
| PPVFVSVYLNRSWLG | 256 | Q12791 | |
| LVSSSRYPDQWIVPG | 36 | A0A024RBG1 | |
| VSGWGTISSPIARYP | 161 | Q9P0G3 | |
| GWVTTDSPYIIPQHR | 206 | P55073 | |
| RPGAVPQAYLTASVW | 311 | Q9NS67 | |
| YVDEVVRNAPWTLTP | 141 | P49585 | |
| PYSVISDSPRSWIQV | 266 | Q96RD9 | |
| LVSSSRYPDQWIVPG | 36 | Q9NZJ9 | |
| PVEYTAVSVLAGPRW | 96 | Q9BW91 | |
| IPWEAGARQISYSIP | 26 | Q9Y5H3 | |
| FLSLWEIYVSPRSPG | 11 | Q9H295 | |
| AGWYGPRVTNSSITI | 236 | Q9H4M3 | |
| VVTITWGGYAIPRSP | 546 | Q14315 | |
| QRSLEPGTPRWANYV | 96 | P51570 | |
| DAAPVTTWLNPLGIY | 261 | Q9H7Z3 | |
| ILYTWPANDRPSTRS | 1101 | Q9Y4C0 | |
| IPYAVVSVWSAFGRP | 266 | Q6U736 | |
| YLEPSQLGWEPLVSS | 1676 | Q6ZR08 | |
| IEPNLPSYRITWTGK | 176 | P27487 | |
| QYRSLWDPTGNLSPT | 371 | P47870 | |
| TGDYASEIAPTRPRW | 1036 | Q96RT7 | |
| GWDIITLGQVTPTLY | 246 | Q8TCJ0 | |
| YSPYQLTWGRPSTRI | 251 | P25963 | |
| SNEVVTLWYRPPDVL | 346 | Q00537 | |
| IWGNSTEYRPTPVEE | 1036 | Q9UKX5 | |
| QPPSGEWLYLDTLVT | 1046 | Q9BZ72 | |
| GYLPSDSQDWRTIIP | 26 | Q8TDV0 | |
| SVPPRLVSAVTWLGY | 376 | P21917 | |
| REPPDWLVTTNYGVR | 191 | A6NMN3 | |
| WLPGRNTSPDTNYTL | 146 | P78552 | |
| VGPGYIDTSIRPWNT | 356 | Q5SRI9 | |
| SENYSGWNRITIPLP | 626 | P78509 | |
| SQPVTWAIDNVYIGP | 2116 | P78509 | |
| VIRYNGTVTWTPPAN | 151 | P30532 | |
| RSYGTASPVANRWTP | 191 | Q8WWV6 | |
| TYGTPSLWARLSVGV | 51 | O43464 | |
| YTVRVANPPFSTWIL | 81 | P26951 | |
| ETLIAYWQRAPSPEV | 1351 | Q96BY6 | |
| LLVWNYEGTSSIPGP | 36 | P11511 | |
| IWINTPEQTVPYGLS | 116 | P14138 | |
| APSGVLVYQITWTPL | 671 | Q9P218 | |
| PSWPLYLSANVGIQV | 301 | Q9Y6R7 | |
| RVLTTGYWPTQSATP | 506 | Q13618 | |
| SVYVTWIPRANGGSP | 736 | Q4KMG0 | |
| EVVWQRGLPSIPYSQ | 76 | Q86WZ0 | |
| PEASYRPVQGALRWT | 401 | Q86WZ0 | |
| GPAQVSWPQLLSTYR | 191 | Q8NEV9 | |
| SQSLPLTYGPEGWIL | 21 | Q6ZV80 | |
| ILTCPQYPGSEILWQ | 46 | P07766 | |
| AWAVPVVLGPSRSNY | 266 | P51993 | |
| TSLPPGNFYTSQILW | 136 | Q68D51 | |
| AGRTPNSYLTQAPVW | 66 | P0C7T7 | |
| LVSGYTPGTINITWL | 136 | P01854 | |
| VSWSPVPGATQYRII | 526 | Q02388 | |
| PISPYTGWLLTITET | 1591 | Q5TBA9 | |
| YALGVVLQDPNTWPS | 366 | Q6UW02 | |
| WRSSNASPYLVPGLV | 461 | Q9H4B8 | |
| YLWATIQRIPEVPGS | 321 | Q02742 | |
| LWRQISPQPSTGLIY | 561 | Q6SJ93 | |
| TGCEPIPVRYLEWSN | 576 | Q13255 | |
| IPWRAVGSPYVVEST | 156 | O14556 | |
| QVLSTGGWIPRTTDY | 16 | Q9UGM3 | |
| GGWIPRTTDYASLIP | 21 | Q9UGM3 | |
| TSYPRPQVTWFREGH | 216 | Q7Z5N4 | |
| PAYDWSPEIQGIILS | 101 | Q9Y2C5 | |
| SSPGVYARVTKLIPW | 241 | P17538 | |
| LRGVYPGSPTSWLVV | 51 | Q92523 | |
| PTQLVSYFRAQGWAP | 506 | Q99829 | |
| IFSVGPVSPSRRWSY | 181 | Q8N6C8 | |
| APPQLASVGATYLWI | 286 | P28827 | |
| TWSRYPSPLEANITL | 111 | Q96CW9 | |
| PGTVIDVEVTRPEWY | 761 | Q96J94 | |
| WAVPVVLGPSRSNYE | 281 | Q11128 | |
| TAPRYPQTGDLSAEW | 406 | C9JL84 | |
| SLPRTSLVQAWPGYT | 336 | Q6NW40 | |
| AVPPGWGTVSSYNVL | 321 | O15034 | |
| TRVADVVTPLWTVPY | 166 | Q8IZ69 | |
| ELTPWIPVIAARSSY | 426 | Q8IYL2 | |
| IDSPQRLVYSPSWCG | 166 | Q8IWB6 | |
| VAVTRPVTWQLEYPG | 361 | Q24JP5 | |
| RAEPAWSPQLLVYSS | 346 | Q7L2K0 | |
| VAAQGISWSYRPEPT | 36 | P12259 | |
| IFSVGPVSPSRRWSY | 181 | O75019 | |
| WDEGYSTLSIPPERL | 526 | Q3BBV2 | |
| WDEGYSTLSIPPERL | 561 | Q86T75 | |
| SWDEGYSTLSIPPER | 831 | Q5TAG4 | |
| LEVAPGYPQSTARDW | 506 | Q9ULZ9 | |
| LGIIYTSTPWEPESL | 946 | Q8IVG5 | |
| QVPETYAVVLSRPAW | 61 | Q0VDG4 | |
| ILYTWPANDRPSTRS | 96 | Q9HDB5 | |
| DLTVITPVFWPGQTR | 831 | O14841 | |
| PGWLADGSVRYPIQT | 306 | O14594 | |
| EYVAQNTPVTWLVGP | 406 | O60664 | |
| LPEGWSLPSYVSVLV | 41 | Q9HAB3 | |
| TSTVRLDVSYPPWNL | 236 | Q9NYZ4 | |
| EWPLESVSYTIRGPT | 71 | Q9H0F6 | |
| ILYDQTGRPILWSPV | 1821 | Q9UKZ4 | |
| TGRPILWSPVSRYNE | 1826 | Q9UKZ4 | |
| ATPGYRWQIVPNASS | 346 | P08F94 | |
| ETEQLRIGPYSWTPF | 221 | Q96AB6 | |
| RPEYAWIVQPVSGAV | 1136 | Q12769 | |
| QGSIGAWRTISPYLS | 71 | Q9NP91 | |
| AWRTISPYLSGVGVA | 76 | Q9NP91 | |
| YTRIPQVPWTTVGLC | 96 | Q8IZV2 | |
| FLTTVWTRPGPEVLN | 591 | Q9P2E5 | |
| ERIATPFQVYSWTAP | 311 | O75153 | |
| WIPSNYPITENIRAI | 151 | Q9BTX7 | |
| YIWPSSDINTIPGEL | 61 | Q9NUQ7 | |
| ATPGWIENILSVQPY | 206 | Q96CW6 | |
| PLAGILVQYTGWSSV | 231 | Q9P2U8 | |
| EPASYGRQDATVWIP | 411 | Q9Y2H5 | |
| YFWPSIPTVSGQIEN | 11 | Q8TF68 | |
| IPQTVLWRYTGTRPS | 326 | Q9HAW8 | |
| GDNIYEWRSTILGPP | 81 | Q96LR5 | |
| EWRSTILGPPGSVYE | 86 | Q96LR5 | |
| PWPTNVLLYGSLVSA | 16 | Q2QL34 | |
| RHFTEQWYPVTLPTG | 356 | Q96PV0 | |
| PGTSVEYLAPWANQI | 121 | Q2QD12 | |
| LPEGWSLPSYLSVVV | 41 | Q9NWF4 | |
| LSQSALPYRRSVPTW | 11 | P62277 | |
| VYGLASPPWRVLASS | 291 | Q5TEJ8 | |
| PQTVLWRYTGTRPSN | 331 | P35504 | |
| IYRLPGVLTWPTSNV | 606 | P53804 | |
| LTPYSTIDTWPGRRS | 191 | O75631 | |
| YVNDSVWVPGPTDDR | 886 | Q9UQG0 | |
| EIRTPDINPAWYASR | 31 | P81277 | |
| IPVPGDDSQTIYVWL | 266 | Q96GW9 | |
| IPQTVLWRYTGTRPS | 326 | O60656 | |
| APGYRSALWLTPEQT | 751 | Q96JE7 | |
| AVVDYVEPSPQGTRW | 66 | Q9NNW7 | |
| GPWCYTTDPTVRRQE | 166 | P00734 | |
| GDINWIRPTLGIPTY | 276 | Q9WJR5 | |
| PGTSVEYLAPWANQI | 121 | Q96AT9 | |
| IYEWRSTILGPPGSV | 76 | P51965 | |
| VNWEDRPSTPTILGY | 101 | P57768 | |
| VATELVPYTPQITAW | 81 | Q9BT76 | |
| LGPARSYPATITTIW | 721 | Q9HD43 | |
| PARYLGEVTGPATWS | 11 | Q13487 | |
| GPNLTATVVWIDPTY | 681 | Q9H1B5 | |
| LTSSWYNPRPLEGNV | 121 | A6NL46 | |
| IPQTVLWRYTGTRPS | 326 | Q9HAW7 | |
| IPQTVLWRYTGTRPS | 326 | Q9HAW9 | |
| PQTVLWRYTGTRPSN | 331 | P22310 | |
| AEAVQRLLYVPPTWT | 201 | Q5T447 | |
| EISRNYVVLSWEPPT | 521 | P54296 | |
| LPAPDVSWYLNGRTV | 276 | Q9UBF9 | |
| VWPRYSASLQPVVDS | 386 | Q14957 | |
| PGLYISLVTWQRPDA | 61 | Q92692 |